-
Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: A pooled analysis of two randomized controlled trials.
Crits-Christoph P, Gallop R, Sadicario JS, Markell HM, Tang W, He H, Tu X, Woody G. Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: A pooled analysis of two randomized controlled trials. Substance Abuse Treatment, Prevention, and Policy 2014;9:3.
-
Does treatment fidelity predict client outcomes in 12-step facilitation for stimulant abuse?
Guydish JR, Campbell BK, Manuel JK, Delucchi KL, Le T, Peavy KM, McCarty D. Does treatment fidelity predict client outcomes in 12-step facilitation for stimulant abuse? Drug and Alcohol Dependence 2014;134(1):330-336.
-
Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.
Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, Weiss RD. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. American Journal of Drug and Alcohol Abuse 2014;40(2):157-162.
-
A comparison of five recursive partitioning methods to find person subgroups involved in meaningful treatment-subgroup interactions.
Doove LL, Dusseldorp E, Van Deun K, Van Mechelen I. A comparison of five recursive partitioning methods to find person subgroups involved in meaningful treatment-subgroup interactions. Advances in Data Analysis and Classification 2014;8(4):403-425.
-
Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment.
Winhusen TJ, Kropp FB, Theobald J, Lewis DF. Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment. Drug and Alcohol Dependence 2014;134(1):391-395.
-
The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.
Nielsen S, Hillhouse M, Weiss RD, Mooney L, Potter JS, Lee J, Gourevitch MN, Ling W. The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample. American Journal on Addictions 2014;23(4):343-348.
-
Associations between post-traumatic stress symptoms, stimulant use, and treatment outcomes: A secondary analysis of NIDA’s Women and Trauma study.
Ruglass LM, Hien DA, Hu M, Campbell ANC. Associations between post-traumatic stress symptoms, stimulant use, and treatment outcomes: A secondary analysis of NIDA's Women and Trauma study. American Journal on Addictions 2014;23(1):90-95.
-
Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females.
Clarke T-K, Crist RC, Ang A, Ambrose-Lanci L, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody GE, Berrettini WH. Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females. Pharmacogenomics Journal 2014;14:303-308.
-
Indirect effects of 12-session seeking safety on substance use outcomes: Overall and attendance class-specific effects.
Morgan-Lopez AA, Saavedra LM, Hien DA, Campbell ANC, Wu E, Ruglass LM, Patock-Peckham JA, Bainter SC. Indirect effects of 12-session seeking safety on substance use outcomes: Overall and attendance class-specific effects. American Journal on Addictions 2014;23(3):218-25.
-
Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence.
Meade CS, Bevilacqua LA, Moore ED, Griffin ML, Gardin JG II, Potter JS, Hatch-Maillette MA, Weiss RD. Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence. American Journal on Addictions 2014;23(1):27-33.